Trials / Completed
CompletedNCT01857297
A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers
A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2013/2014 Formulation of the Enzira® Vaccine in Two Groups of Healthy Volunteers: 'Adults' (Aged 18 to 59 Years) and 'Older Adults' (Aged 60 Years or Older).
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Seqirus · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a study to assess the immune (antibody) response and safety of the 2013/2014 formulation of Enzira® vaccine in healthy adult volunteers aged 18 years or older.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Enzira® vaccine |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2013-05-20
- Last updated
- 2018-06-27
- Results posted
- 2014-01-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01857297. Inclusion in this directory is not an endorsement.